Related Experiment Video
Updated: Apr 8, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Widespread Bordetella parapertussis Infections-Wisconsin, 2011-2012: Clinical and Epidemiologic Features and
Ruth Koepke1, Michael L Bartholomew2, Jens C Eickhoff3
1Division of Public Health, Wisconsin Department of Health Services Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison.
Background:
During October 2011-December 2012, concurrent with a statewide pertussis outbreak, 443 Bordetella parapertussis infections were reported among Wisconsin residents. We examined clinical features of patients with parapertussis and the effect of antibiotic use for treatment and prevention.
Methods:
Patients with polymerase chain reaction results positive for B. parapertussis reported during October 2011-May 2012 were interviewed regarding presence and durations of pertussis-like symptoms and receipt of azithromycin treatment. Data regarding acute cough illnesses and receipt of azithromycin prophylaxis among parapertussis patient household members (HHMs) were also collected. Using multivariate repeated measures log-binomial regression analysis, we examined associations of treatment receipt by the HHM with the earliest illness onset and prophylaxis receipt among other HHMs with the presence of any secondary cough illnesses in the household.
Results:
Among 218 patients with parapertussis, pertussis-like symptoms were frequently reported. Illness durations were significantly shorter among patients with treatment initiated 0-6 days after cough onset, compared with nonrecipients (median durations: 10 vs 19 days, P = .002). Among 361 HHMs from 120 households, compared with nonrecipients, prompt prophylaxis of HHMs was associated with no secondary cough illnesses (relative risk: 0.16; 95% confidence interval, .04-.69).
Conclusions:
Bordetella parapertussis infection causes pertussis-like illness that might be misclassified as pertussis if B. parapertussis testing is not performed. Prompt treatment might shorten illness duration, and prompt HHM prophylaxis might prevent secondary illnesses. Further study is needed to evaluate antibiotic effectiveness for preventing parapertussis and to determine risks and benefits of antibiotic use.
Insights
Bordetella parapertussis causes pertussis-like illness. Early azithromycin treatment shortened illness duration, and prompt household prophylaxis prevented secondary infections during a pertussis outbreak.
Area of Science:
- Bacteriology
- Infectious Diseases
- Public Health
Background:
- A statewide pertussis outbreak in Wisconsin (October 2011-December 2012) coincided with 443 reported Bordetella parapertussis infections.
- This study investigated the clinical presentation of B. parapertussis infections and the impact of antibiotic interventions.
Purpose of the Study:
- To describe clinical features of Bordetella parapertussis infections.
- To evaluate the effectiveness of azithromycin treatment for patients and prophylaxis for household members (HHMs).
Main Methods:
- Interviewed patients with B. parapertussis (PCR-positive) about symptoms and azithromycin treatment.
- Collected data on acute cough illnesses and azithromycin prophylaxis among HHMs.
- Used regression analysis to assess associations between antibiotic receipt and illness outcomes.
Main Results:
- Among 218 B. parapertussis patients, pertussis-like symptoms were common.
- Treatment initiated within 0-6 days of cough onset significantly reduced illness duration (10 vs 19 days).
- Prompt prophylaxis in HHMs was linked to a significant reduction in secondary cough illnesses (RR 0.16).
Conclusions:
- Bordetella parapertussis causes pertussis-like illness, potentially misdiagnosed without specific testing.
- Early antibiotic treatment may shorten illness duration.
- Household prophylaxis appears effective in preventing secondary B. parapertussis infections.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
04:47Author Spotlight: Controlled Human Exposure Model for Tick Research and Lyme Disease Studies
Published on: December 1, 2023
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Investigation of Disease Outbreaks
Diphtheria
Acute Pyelonephritis II: Diagnostic Studies and Management